TY - JOUR T1 - Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSF JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med DO - 10.3949/ccjm.87a.ccc057 AU - Leonard H. Calabrese AU - Tiphaine Lenfant AU - Cassandra Calabrese Y1 - 2020/08/04 UR - http://www.ccjm.org/content/early/2020/08/12/ccjm.87a.ccc057.abstract N2 - Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been used experimentally in patients with acute respiratory distress syndrome. Recombinant GM-CSF administered by direct inhalation is currently being studied in a cohort of patients with advanced COVID-19. ER -